Moderna (MRNA) EBT Margin (2017 - 2026)
Moderna (MRNA) posted quarterly EBT Margin of 528.97% for Q2 2026, up 4709.0% year-over-year from 11.0% in Q2 2025, and down 54.25% on a QoQ basis from 342.93% in Q1 2026.
Moderna (MRNA) EBT Margin (2017 - 2026) Analysis & Trends
Moderna has reported EBT Margin for 10 years, with the latest figure at 528.97% in Q2 2026.
- EBT Margin for Q2 2026 came in at 528.97%, up 4709.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 138.55% (down 4288.0% YoY), and the FY2025 annual result was 142.39%, down 3092.0% from the prior year.
- EBT Margin fell to 528.97% in Q2 2026, from 342.93% in the prior quarter.
- Over five years, EBT Margin peaked at 69.72% in Q1 2022 and troughed at 892.59% in Q1 2025.
- A 5-year average of 236.96% and a median of 112.39% in 2023 frame the typical range for EBT Margin.
- The widest annual swing landed in 2024, when EBT Margin plunged 68122 bps; it then jumped 54966 bps in 2026.
- A 5-year view of EBT Margin shows it stood at 32.55% in 2022, then slumped by 92 bps to 2.49% in 2023, then slumped by 5022 bps to 122.57% in 2024, then increased by 4 bps to 117.85% in 2025, then plunged by 349 bps to 528.97% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 528.97% in Q2 2026, 342.93% in Q1 2026, and 117.85% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Roivant Sciences | 26.52 Bn | 26.52 Bn | 1.16 Mn | -20,427.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -528.97% |
| Mar 31, 2026 | -342.93% |
| Dec 31, 2025 | -117.85% |
| Sep 30, 2025 | -18.41% |
| Jun 30, 2025 | -576.06% |
| Mar 31, 2025 | -892.59% |
| Dec 31, 2024 | -122.57% |
| Sep 30, 2024 | 1.13% |
| Jun 30, 2024 | -530.71% |
| Mar 31, 2024 | -697.60% |
| Dec 31, 2023 | 2.49% |
| Sep 30, 2023 | -106.94% |
| Jun 30, 2023 | -508.43% |
| Mar 31, 2023 | -16.38% |
| Dec 31, 2022 | 32.55% |
| Sep 30, 2022 | 36.18% |
| Jun 30, 2022 | 52.10% |
| Mar 31, 2022 | 69.72% |
| Dec 31, 2021 | 75.02% |
| Sep 30, 2021 | 71.48% |